Axon increases FY25 revenue forecast to $2.74B, up from $2.65B-$2.73B
FY25 Revenue and EBITDA Margin: The consensus for FY25 revenue is projected at $2.72 billion, with an expected Adjusted EBITDA margin of 25%, consistent with previous guidance.
Stock-Based Compensation Expenses: The company anticipates stock-based compensation expenses to be between $580 million and $630 million, which includes approximately $330 million related to the 2024 eXponential Stock Plan and CEO Performance Award.
CapEx Plans for 2025: Expected capital expenditures for 2025 are estimated to be between $170 million and $180 million, focusing on long-term R&D investments, capacity expansion, and new product development.
Headquarters Investment: The anticipated capital expenditures do not cover costs for a new headquarters, as the company is currently awaiting local zoning and planning decisions.
Trade with 70% Backtested Accuracy
Analyst Views on AXON
About AXON
About the author

Axon Stock Declines Amid Broader SaaS Sell-Off
- Significant Stock Drop: Axon's shares fell 19.1% this week, despite the absence of company-specific negative news, reflecting a broader sell-off trend in high-priced SaaS stocks that may impact investor confidence.
- Market Sentiment Shift: This week, industry giants like Microsoft, ServiceNow, and SAP experienced double-digit declines, even though their earnings reports were largely in line with expectations, indicating a notable shift in market sentiment towards the software sector, affecting Axon as well.
- Valuation Context: With a current price-to-sales ratio of 16, Axon is still considered expensive, but this represents a significantly more attractive price compared to its trading levels over the past year and a half, potentially offering a buying opportunity for investors.
- Future Earnings Expectations: Axon is set to report its fourth-quarter earnings on February 24, with analysts forecasting a 31.3% revenue growth to $755.3 million, but a drop in adjusted earnings per share from $2.08 to $1.60 due to increased spending on new technologies and acquisitions, making this a crucial moment to assess its market position.

Axon Shares Plunge 19.1% Amid Broader SaaS Sell-Off
- Stock Price Decline: Axon Enterprise's shares fell 19.1% this week without any specific negative news, indicating a broader sell-off in the software-as-a-service (SaaS) sector due to concerns over AI disruption and high valuations, reflecting a significant shift in market sentiment.
- Market Performance Analysis: As of Friday noon, Axon's stock primarily dropped on Wednesday and Thursday, despite earnings results from industry giants like Microsoft, ServiceNow, and SAP being in line with estimates, their stocks still saw double-digit declines, exacerbating market unease.
- Strong Competitive Advantages: Despite the competitive threat from AI, Axon has established a robust competitive edge with its TASERs and body cameras, along with software that manages evidence and records, making it a clear leader in law enforcement technology that is unlikely to be unseated in the short term.
- Future Outlook: Axon currently trades at a price-to-sales ratio of 16, which, while not cheap, is an improvement compared to its trading levels over the past year and a half; the company is expected to report fourth-quarter earnings on February 24, with revenue projected to grow 31.3% to $755.3 million, although adjusted earnings per share are anticipated to decline, reflecting increased spending on new technology investments.






